Medical Week Daily

Medical news today: Sunday, November 1, 2026

Hospital admits failures in toddler's death, Sun Pharma profit falls 36%, court discharges ex-drugs controller in Biocon case

Get tomorrow's issue in your inbox.

  1. 01

    Radiologists warn Welsh cancer patients deteriorate amid staff gaps

    Source: BBC Health

    BBC Health reports: North and west Wales have a 42% shortfall in consultant radiologists, compared to 22% in south Wales.

    Why it mattersRadiologists say north and west Wales face a 42% shortfall in consultant radiologists versus 22% in the south, and link the gap to cancer patients deteriorating while they wait. More on Oncology →

  2. 02

    Sun Pharma wins CDSCO nod for generic semaglutide pill

    Source: Medical Dialogues

    Sun Pharma has reportedly received approval to make and market once-daily oral semaglutide (3, 7 and 14 mg) for type 2 diabetes, equivalent to Rybelsus; a Delhi High Court order requires it to return to court before launch amid Novo Nordisk's patent suit.

    Why it mattersAnother Indian generic of oral semaglutide could widen access to the GLP-1 pill for type 2 diabetes, though launch timing still depends on the patent case. More on Approvals & regulatory →

  3. 03

    Sun Pharma shares rise even as Q2 profit falls 36% year on year

    Source: Livemint

    Livemint reports that Sun Pharma's shares gained despite the drugmaker's second-quarter profit slipping 36% from a year earlier.

    Why it mattersSun Pharma is one of India's largest medicine makers, so its results are watched as a signal for the wider generic-drug industry. Not investment advice. More on Pharma industry →

    Market news · Not investment advice

  4. 04

    CBI court discharges former joint drugs controller in 2022 Biocon bribery case

    Source: Livemint

    Livemint reports that a CBI court has discharged a former joint drugs controller in the 2022 bribery case linked to Biocon.

    Why it mattersThe case concerned India's drug-approval process, so its outcome matters for trust in how medicines are cleared for patients. More on Approvals & regulatory →

  5. 05

    New Isle of Man charity uses outdoor activities to support men's mental health

    Source: BBC Health

    BBC Health reports: A new charity hopes to use outdoor activities to improve men's mental health on the Isle of Man.

    Why it mattersCommunity-based outdoor programmes are one low-cost way services are trying to reach men, who are often less likely to seek help. More on Infectious disease →

  6. 06

    Hospital admits full responsibility for 24 failures behind toddler's death

    Source: BBC Health

    BBC Health reports: Eleanor Aldred-Owen died after surgery because an abnormal scan was not flagged.

    Why it mattersIt shows how a single unflagged abnormal scan can cascade into fatal harm, and why hospitals need reliable systems for following up test results. More on Drug & device safety →

New here? How to read this digest
Each story links to its original source. "Why it matters" explains what it means for you in plain language. This is news, not medical advice: talk to your doctor about your own care. Browse all topics or the archive.

More recent digests

Free daily email

The day's approvals, safety signals and trials, in five minutes.

Join the list with just your email. You can also follow the RSS feed.

Free, one field, no spam. We only use your address to send Medical Week Daily and never sell it. Ask to be removed any time via the contact page. See the privacy note.

For information and education only. Not medical advice. Medical Week Daily summarizes published health news in plain language for general readers. It does not replace advice from your doctor, product labeling or regulatory documents. Always consult a qualified healthcare professional about your own care, and check the original source. Full medical disclaimer